http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1462117-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate | 2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a680442dede2d7f653fa5a5c7431cca3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b59dbd24768a4e8417aa236735bab75b |
| publicationDate | 2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1462117-A1 |
| titleOfInvention | Method for in vivo detection of antipsychotic properties of dopamine D3 receptor ligands |
| abstract | The invention provides a method in vivo detecting anti-D 3 receptornactivity of dopamine D 3 receptor ligands. The method of the invention makes use of anNMDA glutamate receptor antagonist to induce D 3 -mediated behavioral abnormalitiesnand assess reversing effects of candidate ligands. The invention further relates to thenuse of a dopamine D 3 receptor partial agonist or antagonist for the treatment of ansubstance-induced psychotic disorder or a dyskinesia associated with associatednwith dopamine agonist therapy. |
| priorityDate | 2003-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 280.